Skip to content
Brazil
-
Kyowa Kirin signs exclusive Poteligeo distribution deal with Knight Therapeutics in Latin America
The deal gives Kyowa Kirin access to Knight’s pan-American commercial infrastructure while allowing Knight to add a targeted oncology therapy to its portfolio.
-
MiRecule partners with Rio Biofarma Brasil to develop next-generation extra-hepatic RNA delivery platforms
Under the agreement, MiRecule will combine its NAVIgGator platform, which is designed to support the development of precision RNA medicines, with RBBL’s expertise in peptide discovery, development, and manufacturing.
-
Gilead, Merck present pivotal Phase 3 Islend data for first once-weekly oral HIV regimen
Researchers presented the findings at the 26th International AIDS Conference in Rio de Janeiro, Brazil.
-
Sanofi disinvests Brazilian generics unit Medley to EMS in USD500M deal
Rather than consolidating operations through plant closures, EMS intends to retain Medley’s existing facilities and invest in future expansion.